EUVIMEDEUVIMED entdecken
Crossref

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Effects of postoperative fluids beyond the first 24 h

Yael Berger, Brianne J Sullivan, Eliahu Y Bekhor, Matthew Carpiniello, Natasha L Leigh, Eric R Pletcher, Daniel Solomon, Umut Sarpel, Spiros P Hiotis, Daniel M Labow, Noah A Cohen, Benjamin J Golas

Journal of Surgical Oncology · 2023-12 · 128 (7) · 1133-1140

DOI: 10.1002/jso.27407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 30.07.2023. Verfasst von Yael Berger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Hyperthermic Intraperitoneal Chemotherapy, Cytoreduction Surgical Procedures, Peritoneal Neoplasms, Postoperative Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives There are no guidelines for intravenous fluid (IVF) administration after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). This study assessed rates of post‐CRS/HIPEC morbidity according to perioperative IVF administration.

Methods

All patients undergoing CRS/HIPEC March 2007 to June 2018 were reviewed, recording clinicopathologic, operative, and postoperative variables. Patients were divided by peritoneal cancer index (PCI), comparing IVF volumes and types administered intraoperatively and during the first 72 h postoperatively. Optimal IVF rate cutoffs calculated using area under the receiver operating characteristic curves and Youden's index determined associations with complications.

Results

Overall, 185 patients underwent CRS/HIPEC, and 81 (51%) had low PCI (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperthermic Intraperitoneal ChemotherapyCytoreduction Surgical ProceduresPeritoneal NeoplasmsPostoperative ComplicationsFluid TherapyHumansFemaleMaleMiddle AgedRetrospective StudiesAdultCombined Modality TherapyAgedFollow-Up Studies

Autor:innen und Institutionen

  • Department of Surgery, Division of Surgical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Zitieren

APA

Berger, Y., Sullivan, B. J., Bekhor, E. Y., Carpiniello, M., Leigh, N. L., Pletcher, E. R., Solomon, D., Sarpel, U., Hiotis, S. P., Labow, D. M., Cohen, N. A., & Golas, B. J. (2023). Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Effects of postoperative fluids beyond the first 24 h. Journal of Surgical Oncology, 128(7), 1133-1140. https://doi.org/10.1002/jso.27407

Vancouver

Berger Y, Sullivan BJ, Bekhor EY, Carpiniello M, Leigh NL, Pletcher ER, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Effects of postoperative fluids beyond the first 24 h. Journal of Surgical Oncology. 2023;128(7):1133-1140. doi:10.1002/jso.27407

BibTeX
@article{Berger2023,
  author = {Berger, Yael and Sullivan, Brianne J and Bekhor, Eliahu Y and Carpiniello, Matthew and Leigh, Natasha L and Pletcher, Eric R and Solomon, Daniel and Sarpel, Umut and Hiotis, Spiros P and Labow, Daniel M and Cohen, Noah A and Golas, Benjamin J},
  title = {Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Effects of postoperative fluids beyond the first 24 h},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  volume = {128},
  number = {7},
  pages = {1133--1140},
  doi = {10.1002/jso.27407}
}
Kostenlos starten →